By
Drug Target Review2025-06-28T10:00:52
Amelie Croset of Molecular Partners breaks down the DARPin developments featured at AACR 2025 – from targeted radiopharmaceuticals to precision-engineered immune cell engagers.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-20T13:00:00Z
2026-11-20T08:00:00Z
Contributor Dr Rahul Gupta, By Drug Target Review
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
2026-10-30T07:30:00
Sponsored by Aptamer Group
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2023-03-28T11:38:32
Sponsored by Bio-Techne
2023-11-24T12:06:45
Sponsored by Quantum-Si
2024-01-10T08:56:17
Sponsored by Leica Microsystems
Site powered by Webvision Cloud